Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acura Pharmaceuticals Inc (NASDAQ:ACUR)

3.28
Delayed Data
As of Apr 29
 +0.025 / +0.77%
Today’s Change
1.61
Today|||52-Week Range
6.75
+31.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues5.4M341.0K210.0K2.7M
 
 
 
 
 
Cost of Goods Sold242.0K18.0K47.0K17.0K
 
 
 
 
 
Depreciation And Amortization82.0K80.0K85.0K85.0K
 
 
 
 
 
 
Operating ExpensesGross Income5.0M243.0K78.0K2.6M
 
 
 
 
 
General Expenses3.3M2.6M2.5M3.3M
 
 
 
 
 
Other Operating Expenses260.0K47.0K27.0K0.00
 
 
 
 
Research And Development964.0K511.0K432.0K701.0K
 
 
 
 
 
Total Operating Expenses3.8M2.7M2.6M3.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.5M-2.4M-2.4M-714.0K
 
 
 
 
 
Interest Expense On Debt308.0K301.0K283.0K265.0K
 
 
 
 
 
Other Expenses0.000.000.007.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.2M-2.7M-2.6M-916.0K
 
 
 
 
 
Net Income1.2M-2.7M-2.6M-916.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.8M9.8M11.7M11.8M
 
 
 
 
 
Shares To Calculate EPS Diluted9.9M9.8M11.7M11.8M
 
 
 
 
 
 
Earnings Per ShareEPS$0.15-$0.25-$0.23-$0.08
 
 
 
 
 
EPS Diluted$0.15-$0.25-$0.23-$0.08